Peter Diamandis - Nov 18, 2021 Form 4/A - Amendment Insider Report for Vaxxinity, Inc. (VAXX)

Role
Director
Signature
/s/ Rene Paula Molina, attorney-in-fact for Peter Diamandis
Stock symbol
VAXX
Transactions as of
Nov 18, 2021
Transactions value $
-$3,224
Form type
4/A - Amendment
Date filed
6/23/2022, 07:47 PM
Date Of Original Report
Nov 18, 2021
Previous filing
Jun 23, 2022
Next filing
Jun 23, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VAXX Class A common stock Sale -$3.22K -248 -0.27% $13.00* 90.5K Nov 18, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 In the Form 4 filed on November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction.

Remarks:

On November 18, 2021, the Reporting Person omitted this sale of stock to cover fees in connection with the previously reported transaction.